A PEPTIDE MIMICKING VGLL4 FUNCTION ACTS AS A YAP ANTAGONIST THERAPY AGAINST GASTRIC CANCER.

20210801 20180803 20180328 20210801 IID50339 Transcription cofactor vestigial-like protein 4 Mus musculus 287 Q80V24 May act as a specific coactivator for the mammalian TEFs. 0 0 Phosphoserine 58 58 Phosphoserine 271 271 Vgll4 VGLL4_MOUSE MLFMKMDLLNYQYLDKMNNNIGVLCYEGEASLRGEPRMQTLPVASALSSHRTGPPPISPSKRKFSMEPGDKDLDCENDHVSKMSRIFSPHLNKTVNGDCRRDPRERSRSPIERAAAPAVSLHGGHLYASLPSLMEQPLALTKNSSDTGRSAVERQQNRPSVITCASAGARNCNLSHCPIAHSGCSAPGSASYRRPPSATATCDPVVEEHFRRSLGKNYKEPEPAPNSVSITGSVDDHFAKALGDTWLQIKAAKDSASSSPESASRRGQPASPTAHMVSHSHSPSVVS 1 4ln0C 203 252 order 1 2 4ln0C 253 256 disorder 1 1 4ln0 X-RAY 289K 7.5 24525233 S.JIAO,H.WANG,Z.SHI,A.DONG,W.ZHANG,X.SONG,F.HE,Y.WANG,Z.ZHANG,W.WANG,X.WANG,T.GUO,P.LI,Y.ZHAO,H.JI,L.ZHANG,Z.ZHOU A PEPTIDE MIMICKING VGLL4 FUNCTION ACTS AS A YAP ANTAGONIST THERAPY AGAINST GASTRIC CANCER. 2014 CANCER CELL 25 166 x-ray 4ln0 C 203 256 100 1 253 256 1 4ln0_1 2574 Hetero trimer 4ln0C Q80V24 IID50339 4ln0B Q62296 IID50291 4ln0A Q62296 IID50291 4ln0C-4ln0B 4ln0C-4ln0A 4-4,6-17,160-163,203-222,225-225,227-254 1-3,5-5,18-159,164-202,223-224,226-226,255-287 1-34 35-287 35-41,48-88,124-144,159-177,200-217,229-252 251-264,275-287